Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders
申请人:Sugen, Inc.
公开号:US20040102489A1
公开(公告)日:2004-05-27
The present invention relates to novel heteroaryl-carboxamides which modulate the activity of protein tyrosine kinases and therefore are expected to be useful in the treatment of abnormal protein tyrosine kinase activity driven disorders including cancer.
本发明涉及一种新型杂环基-羧酰胺,其可以调节蛋白酪氨酸激酶的活性,因此被期望在治疗异常的蛋白酪氨酸激酶活性驱动的疾病,包括癌症中有用。